UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007848
Receipt number R000009246
Scientific Title Survey of Usage Monitoring of Midazolam and Arousal Level of Flumazenil in Endoscopy
Date of disclosure of the study information 2012/04/27
Last modified on 2012/04/27 15:29:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of Usage Monitoring of Midazolam and Arousal Level of Flumazenil in Endoscopy

Acronym

Survey of Usage Monitoring of Midazolam and Flumazenil in Endoscopy

Scientific Title

Survey of Usage Monitoring of Midazolam and Arousal Level of Flumazenil in Endoscopy

Scientific Title:Acronym

Survey of Usage Monitoring of Midazolam and Flumazenil in Endoscopy

Region

Japan


Condition

Condition

Disease of the need for Gastrointestinal Endoscopy

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Survey of usage monitoring of Midazolam, and analysis of relationship with patient background.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Relationship with drinking history, drug history and BMI

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Range in age from 20 to 60

Key exclusion criteria

1)Case where no consent is obtained.
2)Contraindication or caution to Midazolam or Flumazenil.
3)Acute disease(infection,gastrointestinal bleeding etc.).
4)Therapeutic purpose.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Nagasawa

Organization

Chiba Pharmaceutical Association

Division name

Drug Information Center

Zip code


Address

9-2 Tonyacho, Chuo-ku, Chibashi, Chiba 260-0026, Japan

TEL

(043)247-4401

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Nagasawa

Organization

Secomedic Hospital

Division name

Dispensary

Zip code


Address

696-1 Toyotomicho, Funabashishi, Chiba 274-0053, Japan

TEL

(047)457-9255

Homepage URL


Email

h-nagasawa@secomedic.gr.jp


Sponsor or person

Institute

Secomedic Hospital

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Chiba Pharmaceutical Association
Drug Information Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団誠馨会 セコメディック病院(千葉県)


Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 03 Month 26 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 04 Month 01 Day

Date trial data considered complete

2013 Year 04 Month 01 Day

Date analysis concluded

2013 Year 06 Month 01 Day


Other

Other related information

Ju MIZUNO,Michiko MATSUKI,Yoshinori GOUDA,et al.Antagonizing with Flumazenil after Sedation with Midazolam in Uppr Gastrointestinal Endoscopy.2004;52-5:823-830


Management information

Registered date

2012 Year 04 Month 27 Day

Last modified on

2012 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009246


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name